Regulus Therapeutics
RGLS
#7200
Rank
A$0.85 B
Marketcap
A$12.33
Share price
0.00%
Change (1 day)
423.09%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of March 2025 : A$2.11 Million

According to Regulus Therapeutics's latest financial reports the company's total debt is A$2.11 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.44 M-87.44%
2023-12-31A$3.5 M-62%
2022-12-31A$9.22 M-5.65%
2021-12-31A$9.77 M61.65%
2020-12-31A$6.04 M-71.05%
2019-12-31A$20.89 M-11.18%
2018-12-31A$23.52 M-7.51%
2017-12-31A$25.43 M-7.4%
2016-12-31A$27.47 M
2014-12-31A$28.58 M126.09%
2013-12-31A$12.64 M29.67%
2012-12-31A$9.75 M-0.01%
2011-12-31A$9.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
A$40.65 B 1,920,528.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$12.62 B 596,266.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$67.69 B 3,198,329.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$48.70 B 2,301,042.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$47.49 B 2,243,861.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A$29.2 M 1,279.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.90 B 89,977.80%๐Ÿ‡บ๐Ÿ‡ธ USA